Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 8, 2026 | CMS / Medicare | Billing and Coding: In Vitro Chemosensitivity & Chemoresistance Assays | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: Nerve Conduction Studies and Electromyography | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers | Metadata changed |
| May 8, 2026 | CMS / Medicare | Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for Tremor | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: Magnetic Resonance Angiography | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy | Metadata changed |
| May 8, 2026 | CMS / Medicare | Intervertebral Disc Repair | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: MolDX: BCR-ABL | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: Trigger Point Injections (TPI) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Nerve Blockade for Treatment of Chronic Pain and Neuropathy | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test | Metadata changed |
| May 8, 2026 | CMS / Medicare | Botulinum Toxin Injections | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: Skin Substitutes Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: Polysomnography and Other Sleep Studies | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: Intervertebral Disc Repair | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: Botulinum Toxins | Metadata changed |
| May 8, 2026 | CMS / Medicare | Corneal Pachymetry | Metadata changed |
| May 8, 2026 | CMS / Medicare | Wound Care | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: HLA-DQB1*06:02 | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Colon Capsule Endoscopy (CCE) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Transcatheter Edge-to-Edge Repair (TEER) for Mitral Valve Regurgitation | Metadata changed |
| May 8, 2026 | CMS / Medicare | INDEPENDENCE iBOT 4000 Mobility System | Metadata changed |
| May 8, 2026 | CMS / Medicare | Cardiac Event Detection | Metadata changed |
| May 8, 2026 | National Government Services | Erythropoiesis Stimulating Agents | Metadata changed |
| May 8, 2026 | CMS / Medicare | Cardiac Pacemakers | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Botulinum Toxin Injections DL39909 | Metadata changed |
| May 8, 2026 | CMS / Medicare | Implantable Continuous Glucose Monitors (I-CGM) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Chimeric Antigen Receptor (CAR) T-cell Therapy | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Minimal Residual Disease Testing for Cancer | Metadata changed |
| May 8, 2026 | CMS / Medicare | Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices | Metadata changed |
| May 8, 2026 | CMS / Medicare | Lumbar Spinal Fusion | Metadata changed |
| May 8, 2026 | CMS / Medicare | Implantable Cardioverter Defibrillators (ICDs) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF) | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Algorithm definition as a component of a laboratory test | Metadata changed |
| May 8, 2026 | CMS / Medicare | Wheelchair Seating - Policy Article | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Biomarkers in Cardiovascular Risk Assessment | Metadata changed |
| May 8, 2026 | CMS / Medicare | Wireless Capsule Endoscopy | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Magnetic Resonance Guided Focused Ultrasound Surgery System (MRgFUS) for the treatment of neurologic condition | Metadata changed |
| May 8, 2026 | CMS / Medicare | Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs) | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Breast Cancer Assay: Prosigna | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing Comment Period Ending 05/02/2014. | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Metadata changed |
| May 8, 2026 | CMS / Medicare | Frequency of Hemodialysis | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Biomarker Testing (Prior to Initial Biopsy) for Prostate Cancer Diagnosis | Metadata changed |
| May 8, 2026 | CMS / Medicare | Urine Drug Testing | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Metadata changed |